R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma

Herrmann, 2009, Improvement of overall survival in advanced stage mantle cell lymphoma, J Clin Oncol, 27, 511, 10.1200/JCO.2008.16.8435 Williams, 2013, Transplantation for mantle cell lymphoma: is it the right thing to do?, Hematology Am Soc Hematol Educ Program, 2013, 568, 10.1182/asheducation-2013.1.568 Martin, 2012, Management of mantle cell lymphoma in the elderly, Best Pract Res Clin Haematol, 25, 221, 10.1016/j.beha.2012.04.006 Cortelazzo, 2012, Mantle cell lymphoma, Crit Rev Oncol Hematol, 82, 78, 10.1016/j.critrevonc.2011.05.001 Dreyling, 2005, Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European, Blood, 105, 2677, 10.1182/blood-2004-10-3883 LaCasce, 2012, Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database, Blood, 119, 2093, 10.1182/blood-2011-07-369629 Lenz, 2005, Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma, J Clin Oncol, 23, 1984, 10.1200/JCO.2005.08.133 Howard, 2002, Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival, J Clin Oncol, 20, 1288, 10.1200/JCO.20.5.1288 Merli, 2012, Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi, Br J Haematol, 156, 346, 10.1111/j.1365-2141.2011.08958.x Bernstein, 2013, A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma, Ann Oncol, 24, 1587, 10.1093/annonc/mdt070 Romaguera, 2005, High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine, J Clin Oncol, 23, 7013, 10.1200/JCO.2005.01.1825 Romaguera, 2010, Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma, Br J Haematol, 150, 200 Oinonen, 2002, Autologous stem cell transplantation in patients with mantle cell lymphoma, Leuk Lymphoma, 43, 1229, 10.1080/10428190290026286 Jantunen, 2012, Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT), Ann Oncol, 23, 166, 10.1093/annonc/mdr035 Robinson, 2013, The EBMT lymphoma working party-European mantle cell lymphoma network consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma: recommendations applying the Delphi Procedure [abstract], Blood, 122, 10.1182/blood.V122.21.3405.3405 Delarue, 2013, CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d’Etude des Lymphomes de l'Adulte, Blood, 121, 48, 10.1182/blood-2011-09-370320 Dreyling, 2013, ESMO Consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma, Ann Oncol, 24, 857, 10.1093/annonc/mds643 Abramson, 2013, Recent advances in the treatment of non-Hodgkins lymphoma, J Natl Compr Canc Netw, 11, 671, 10.6004/jnccn.2013.0198 Cheson, 2007, Revised response criteria for malignant lymphoma, J Clin Oncol, 25, 579, 10.1200/JCO.2006.09.2403 Pfreundschuh, 2006, CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group, Lancet Oncol, 7, 379, 10.1016/S1470-2045(06)70664-7 Kluin-Nelemans, 2012, Treatment of older patients with mantle-cell lymphoma, N Engl J Med, 367, 520, 10.1056/NEJMoa1200920 Ahmadi, 2012, Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance, Bone Marrow Transplant, 47, 1082, 10.1038/bmt.2011.218 Dietrich, 2013, Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression free survival in patients with mantle cell lymphoma (abstract), Blood, 122, 10.1182/blood.V122.21.3050.3050